10,000 breast cancer patients to donate samples for future research

NCT ID NCT01000883

Recruiting now Knowledge-focused Sponsor: UNC Lineberger Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects tumor tissue and blood samples from 10,000 women with breast cancer to build a large biorepository. Researchers will analyze these samples to find molecular markers that may predict how well a patient responds to therapy. The goal is to better understand breast cancer behavior and improve future treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify biomarkers that predict how breast cancer patients respond to therapy, potentially guiding more personalized treatment in the future.
What could go wrong: This is an observational study focused on sample collection, not a treatment trial. It may not directly lead to new therapies, and results depend on future research using the samples.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27599-7295, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.